Philip V. D.
- Country
- Belgium
- Department
- Neurology
Research Overview
- Phase 1b Open-Label Study of VRG50635 in Sporadic and Familial Amyotrophic Lateral Sclerosis Patients with Long-Term Treatment
- Safety and Tolerability Evaluation of QRL-201 in Patients with Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
- Multiple Ascending Dose Evaluation of LY4256984 in Patients with Sporadic Amyotrophic Lateral Sclerosis
Data & Insights
Has run more than one trial at 46 of 87 partner sites.
Specializations
Neuromuscular Disorders
Philip van Damme is strongly involved in clinical research on amyotrophic lateral sclerosis, spinal muscular atrophy, muscular dystrophies, myotonic dystrophy, and multifocal motor neuropathy, with additional interest in related motor neuron disease and peripheral neuropathies.
- Amyotrophic lateral sclerosis
- Spinal muscular atrophy
- Duchenne muscular dystrophy
- Myotonic dystrophy
- Multifocal motor neuropathy
His trial portfolio also includes inherited and progressive neuromuscular conditions such as Becker muscular dystrophy, limb-girdle muscular dystrophy, and Charcot-Marie-Tooth disease.
Neurodegenerative and Cognitive Disorders
His clinical research extends to Alzheimer’s disease, frontotemporal dementia, Lewy body dementia, Parkinson’s disease, and progressive supranuclear palsy, reflecting a broad therapeutic focus on neurodegeneration and cognitive decline.
- Alzheimer’s disease
- Frontotemporal dementia
- Lewy body dementia
- Parkinson’s disease
- Progressive supranuclear palsy
He is also involved in studies addressing mild cognitive impairment and preclinical Alzheimer’s disease.
Autoimmune and Inflammatory Diseases
Philip van Damme contributes to research in myasthenia gravis, multiple sclerosis, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis, and idiopathic inflammatory myopathy, with a clear therapeutic interest in immune-mediated neurological and systemic disease.
- Myasthenia gravis
- Multiple sclerosis
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Idiopathic inflammatory myopathy
His portfolio also includes chronic inflammatory demyelinating polyneuropathy, axial spondyloarthritis, and juvenile idiopathic arthritis.
Gastrointestinal and Hepatic Immune-Mediated Disease
He is active in trials for Crohn’s disease, ulcerative colitis, pouchitis, and eosinophilic esophagitis, alongside liver-related immune disorders such as primary biliary cholangitis and primary sclerosing cholangitis.
- Crohn’s disease
- Ulcerative colitis
- Pouchitis
- Eosinophilic esophagitis
- Primary sclerosing cholangitis
His research also covers functional gastrointestinal disorders and inflammatory bowel disease phenotypes with challenging symptom burden.
Neuro-oncology and Other Therapeutic Areas
Philip van Damme is also linked to research in glioblastoma, glioma, medulloblastoma, and brain metastases, as well as selected studies in epilepsy, stroke, and sleep disorders.
- Glioblastoma
- Glioma
- Medulloblastoma
- Epilepsy
- Stroke
His wider clinical scope includes cancer-related neurological complications, neuropathic pain, and rare genetic neurologic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.